Investors

RSS Content

Codexis to Announce Second Quarter 2013 Financial Results on August 7, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 24, 2013-- Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Wednesday, August 7, 2013 at 4:30 p.m. Eastern Time to discuss its second quarter 2013 financial results for the period ended June 30, 2013. The call and webcast will follow the release of second quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.

What:   Codexis' Second Quarter 2013 Financial Results
 

Date:

Wednesday, August 7, 2013
 

Time:

4:30 p.m. ET
 

Live Call:

US: 877-415-3177
International: 857-244-7320
Passcode: 60099547
 

Webcast:

Investors page of www.codexis.com

 

Replay:

US: 888-286-8010
International: 617-801-6888
Passcode: 45333989

About Codexis, Inc.

Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical production. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.

Source: Codexis, Inc.

Codexis, Inc.
Paul Cox, 212-362-1200 (Investors)
ir@codexis.com
or
Jemma Connor, +44 161 359 3255 (Media)
jemma.connor@notchcommunications.co.uk

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share Page

X
| E-mail Alerts E-mail Alerts | IR Contacts Contacts | Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSISTM

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.

PHARMACEUTICAL ENZYMES


Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information
for the investment community

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue